Saturday, 16 May 2020

Zydus Cadila receives tentative approval from USFDA for Droxidopa Capsules

Zydus Cadila has received tentative approval from the USFDA to market Droxidopa Capsules, (US RLD: Northera®) in the strengths of 100 mg, 200 mg, and 300 mg.



source https://www.pharmatutor.org/pharma-news/2020/zydus-cadila-receives-tentative-approval-from-usfda-for-droxidopa-capsules
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Pharmaceutical Industry and pharma / Life Sciences institute openings 2025

  Intas Pharma Walk in Drive for M.Pharm, B.Pharm | Multiple Posts M.Pharma / B.Pharma. Injectable/Parenteral/Sterile - Aseptic, Manufacturi...